Chemours and Solstice Advanced Materials are the chemistry chokepoint for two-phase and immersion cooling, a Western duopoly whose fluids become a recurring consumable if those methods scale. Chemours' Opteon is one of two credible Western two-phase chemistries; it is cheap for real reasons, with PFAS liabilities, a 2024 accounting probe and high leverage, but the risk-reward is interesting. Solstice, the Honeywell spinoff, is the cleaner pure play, adding capacity with backlog over $2 billion. … Show more

Modine Manufacturing is a pure play on data-center thermal management, and its November 18 investor day could send it higher if it confidently sets big 2028-29 targets. It already cites two hyperscalers and one neocloud as customers, and which hyperscalers they are does not matter. Its valuation, which had grown stretched along with Vertiv's, now looks more intriguing than ever. x.com 

This ten-stock portfolio trades at just 3.7x cash flow, so multiple expansion is a major opportunity rather than a risk. Portfolios at 37x cash flow face multiple compression, as Akre Capital's Q1 2026 letter shows: its price to next-twelve-month free cash flow fell from 37x to 19x without any deterioration in operating fundamentals. x.com